Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.

Saved in:
Bibliographic Details
Title: Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.
Authors: Desai AV; Department of Pediatrics, University of Chicago, Chicago, Illinois., Applebaum MA; Department of Pediatrics, University of Chicago, Chicago, Illinois., Karrison TG; Department of Public Health Sciences, University of Chicago, Chicago, Illinois., Oppong A; Pritzker School of Medicine, University of Chicago, Chicago, Illinois., Yuan C; Department of Radiology, University of Chicago, Chicago, Illinois., Berg KR; Children's Hospital of Philadelphia and the University of Pennsylvania, Philadelphia, Pennsylvania., MacQuarrie K; Ann and Robert H. Lurie Children's Hospital of Chicago and Northwestern University, Chicago, Illinois., Sokol E; Ann and Robert H. Lurie Children's Hospital of Chicago and Northwestern University, Chicago, Illinois., Hall AG; Seattle Children's Hospital and University of Washington, Seattle, Washington., Pinto N; Seattle Children's Hospital and University of Washington, Seattle, Washington., Wolfe I; C. S. Mott Children's Hospital and University of Michigan, Ann Arbor, Michigan., Mody R; C. S. Mott Children's Hospital and University of Michigan, Ann Arbor, Michigan., Shusterman S; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts., Smith V; Texas Children's Hospital and Baylor College of Medicine, Houston, Texas., Foster JH; Texas Children's Hospital and Baylor College of Medicine, Houston, Texas., Nassin M; Department of Pediatrics, University of Chicago, Chicago, Illinois., LaBelle JL; Department of Pediatrics, University of Chicago, Chicago, Illinois., Bagatell R; Children's Hospital of Philadelphia and the University of Pennsylvania, Philadelphia, Pennsylvania., Cohn SL; Department of Pediatrics, University of Chicago, Chicago, Illinois.
Source: Cancer [Cancer] 2022 Aug 01; Vol. 128 (15), pp. 2967-2977. Date of Electronic Publication: 2022 Jun 06.
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35665495
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Desai+AV%22">Desai AV</searchLink>; Department of Pediatrics, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Applebaum+MA%22">Applebaum MA</searchLink>; Department of Pediatrics, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Karrison+TG%22">Karrison TG</searchLink>; Department of Public Health Sciences, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Oppong+A%22">Oppong A</searchLink>; Pritzker School of Medicine, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Yuan+C%22">Yuan C</searchLink>; Department of Radiology, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Berg+KR%22">Berg KR</searchLink>; Children's Hospital of Philadelphia and the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22MacQuarrie+K%22">MacQuarrie K</searchLink>; Ann and Robert H. Lurie Children's Hospital of Chicago and Northwestern University, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Sokol+E%22">Sokol E</searchLink>; Ann and Robert H. Lurie Children's Hospital of Chicago and Northwestern University, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Hall+AG%22">Hall AG</searchLink>; Seattle Children's Hospital and University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Pinto+N%22">Pinto N</searchLink>; Seattle Children's Hospital and University of Washington, Seattle, Washington.<br /><searchLink fieldCode="AU" term="%22Wolfe+I%22">Wolfe I</searchLink>; C. S. Mott Children's Hospital and University of Michigan, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Mody+R%22">Mody R</searchLink>; C. S. Mott Children's Hospital and University of Michigan, Ann Arbor, Michigan.<br /><searchLink fieldCode="AU" term="%22Shusterman+S%22">Shusterman S</searchLink>; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Smith+V%22">Smith V</searchLink>; Texas Children's Hospital and Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Foster+JH%22">Foster JH</searchLink>; Texas Children's Hospital and Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Nassin+M%22">Nassin M</searchLink>; Department of Pediatrics, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22LaBelle+JL%22">LaBelle JL</searchLink>; Department of Pediatrics, University of Chicago, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Bagatell+R%22">Bagatell R</searchLink>; Children's Hospital of Philadelphia and the University of Pennsylvania, Philadelphia, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Cohn+SL%22">Cohn SL</searchLink>; Department of Pediatrics, University of Chicago, Chicago, Illinois.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2022 Aug 01; Vol. 128 (15), pp. 2967-2977. <i>Date of Electronic Publication: </i>2022 Jun 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0142 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35665495
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cncr.34263
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2967
    Titles:
      – TitleFull: Efficacy of post-induction therapy for high-risk neuroblastoma patients with end-induction residual disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Desai AV
      – PersonEntity:
          Name:
            NameFull: Applebaum MA
      – PersonEntity:
          Name:
            NameFull: Karrison TG
      – PersonEntity:
          Name:
            NameFull: Oppong A
      – PersonEntity:
          Name:
            NameFull: Yuan C
      – PersonEntity:
          Name:
            NameFull: Berg KR
      – PersonEntity:
          Name:
            NameFull: MacQuarrie K
      – PersonEntity:
          Name:
            NameFull: Sokol E
      – PersonEntity:
          Name:
            NameFull: Hall AG
      – PersonEntity:
          Name:
            NameFull: Pinto N
      – PersonEntity:
          Name:
            NameFull: Wolfe I
      – PersonEntity:
          Name:
            NameFull: Mody R
      – PersonEntity:
          Name:
            NameFull: Shusterman S
      – PersonEntity:
          Name:
            NameFull: Smith V
      – PersonEntity:
          Name:
            NameFull: Foster JH
      – PersonEntity:
          Name:
            NameFull: Nassin M
      – PersonEntity:
          Name:
            NameFull: LaBelle JL
      – PersonEntity:
          Name:
            NameFull: Bagatell R
      – PersonEntity:
          Name:
            NameFull: Cohn SL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2022 Aug 01
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1097-0142
          Numbering:
            – Type: volume
              Value: 128
            – Type: issue
              Value: 15
          Titles:
            – TitleFull: Cancer
              Type: main
ResultId 1